Binance commits $250,000 to support frontline Ebola response in Uganda and DRC
Binance today announced $250,000 in humanitarian funding to support the frontline response to the ongoing Ebola disease…
China launches first large-scale stem cell antiaging trial
A 2,000-person study at Beijing’s renowned 301 Hospital aims to determine whether stem cells can help people maintain…
Alberta health system ‘rudderless,’ doctor says, as latest AHS leader departs
Listen to this article Estimated 4 minutes The audio version of this article is generated by AI-based technology.…
‘Hands Off Our NHS’: Anti-Palantir Protests Break Out in UK Over Deal With National Health Service
“It’s exactly the use case that you don’t outsource, and you certainly don’t outsource outside the country,” Laura…
Should I tell my doctor? Tips for talking about health with a physician
Let’s be frank: When you go to see your personal doctor or stop at an urgent care for…
New virtual care service to offer scheduled appointments, no ‘distracted’ nurses, says N.B. health minister
Listen to this article Estimated 4 minutes The audio version of this article is generated by AI-based technology.…
Mass General Brigham and CVS primary care partnership moves closer to reality
“We’re pleased to move forward with this affiliation at a time when the primary care shortage is being…
Gen Z Are Hitting Up ‘Barmacies’, Where Happy Hour Comes With a Health Diagnosis
Imagine walking into a bar with your friends after a long week at work, only to receive a…
New system for flagging retracted papers finds scores of them in Cochrane reviews – Retraction Watch
Cochrane has implemented a new system for checking whether any of its thousands of published reviews include retracted…
A&E patients with non-urgent ailments may be told to come back later under NHS plans | A&E
Patients who turn up at A&E with non-urgent ailments could be told to come back another time under…
MHRA landmark report reveals public views on AI in healthcare
The MHRA has launched two reports describing the findings of an extensive engagement and evidence gathering programme undertaken…
U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need
Approval expands HYMPAVZI use to now include people with hemophilia A or B ages 12 years and older…